Filing Details
- Accession Number:
- 0001894562-25-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-22 16:22:45
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-22
- Accepted Time:
- 2025-05-22 16:22:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1894562 | Prime Medicine Inc. | PRME | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1692359 | Richard Brudnick | C/O Prime Medicine, Inc. 60 First Street Cambridge MA 02141 | Chief Business Officer | No | Yes | No | No |
Transaction Summary
| Purchased: | 20,000 shares | Avg. Price: $1.19 | Total Value: $23,790.00 |
| Number of Shares After Transactions: | 20,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-20 | 20,000 | $1.19 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
